Canada Spends Logo

Explore our Budget 2026 analysis

Grant: CIHR - ICR / Cancer Research Society Partnership - Research Grants

University of Guelph

$62,500.00

Developing necroptosis for breast cancer immunotherapy

FY 2022-23

Summary
Stressed and dying cellssend several messagesthat educate immune cells whether a danger is apparent or not. We identified that killing tumors with after activating a necroptotic death createsimmune stimulation to provide strong anticancer immunity. By programming tumor cellsto die via a necroptotic pathway, the proposed study will evaluate the magnitude of immune response and aimsto identify the conditionsthat best alarm the immune system. Moreover, thisstudy will use programmable cancer-killing virusesto initiate immune stimulatory cell death thereby allowing the release of tumor cell contentsfor survey by the immune system.
Program
CIHR - ICR / Cancer Research Society Partnership - Research Grants
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database

As published

Id
488239
Name
Workenhe Samuel Tekeste
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Partnername
Cancer Research Society Inc.; Cancer Research Society Inc.
Instname2
Cancer Research
Prcname2
Special Cases
Projecttitle
Developing necroptosis for breast cancer immunotherapy
Programtype2
Operating Grants
Orgnameinp2
University of Guelph
Cihramount2
$62,500
Cihrequipment2
$0
Programname2
CIHR - ICR / Cancer Research Society Partnership - Research Grants
Keyworddelim
Immunotherapy; Oncolytic Viruses & Immunotherapy ; Translational Research
Abstract
Stressed and dying cellssend several messagesthat educate immune cells whether a danger is apparent or not. We identified that killing tumors with after activating a necroptotic death createsimmune stimulation to provide strong anticancer immunity. By programming tumor cellsto die via a necroptotic pathway, the proposed study will evaluate the magnitude of immune response and aimsto identify the conditionsthat best alarm the immune system. Moreover, thisstudy will use programmable cancer-killing virusesto initiate immune stimulatory cell death thereby allowing the release of tumor cell contentsfor survey by the immune system.
Competitiondate
202302
Approvedterm2
1 yr 0 mth
Pinamesdelim
Workenhe, Samuel Tekeste
Approvedterm
1 an 0 mois
Cihrcontribution2
ICR~ $62,500~ $0~